Metabolic Syndrome & T2DM

Metabolic syndrome is a complex disorder characterized by a cluster of metabolic abnormalities including hypertension, obesity, type 2 diabetes, and dyslipidemia. Here is the latest research on metabolic syndrome and type 2 diabetes mellitus.

January 21, 2022
Review

Omics era in type 2 diabetes: From childhood to adulthood.

World Journal of Diabetes
Antonio Paride PassaroAnna Di Sessa
January 21, 2022
Review
Open Access

The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases.

Metabolites
Cengiz CallenderMax Nieuwdorp
January 21, 2022
Open Access

Metabolite Signature of Physical Activity and the Risk of Type 2 Diabetes in 7271 Men.

Metabolites
Susanna Maria KemppainenMarkku Laakso
January 20, 2022

Prognostic value of metabolic syndrome in renal structural changes in type 2 diabetes.

International Urology and Nephrology
Lijun ZhaoFang Liu
January 19, 2022

[Masked arterial hypertension in patients with type2 diabetes mellitus: Prevalence, associated factors and cardiovascular impact].

Annales de cardiologie et d'angéiologie
Faten HadjkacemMohamed Abid
January 19, 2022
Review

Fatty Kidney: A Possible Future for Chronic Kidney Disease Research.

European Journal of Clinical Investigation
Mehmet KanbayKathherine R Tuttle
January 15, 2022

Sleeve gastrectomy versus mini-gastric bypass and their effects on type II diabetes mellitus and weight loss outcome.

Journal of Medicine and Life
Mohammed Abd-Zaid AkoolSafauldeen Salim Al Baaj
January 14, 2022

Prevalence of type 2 diabetes mellitus, metabolic syndrome, and related morbidities in overweight and obese children.

Journal of Pediatric Endocrinology & Metabolism : JPEM
İsmail Dündar, Ayşehan Akıncı
January 13, 2022

Clinical relevance of the relationship between Trabecular Bone Score and metabolic syndrome.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
Chi-Wei ShihWei-Liang Chen
January 13, 2022

IS THE WAIST/HEIGHT RATIO A BETTER PARAMETER THAN BMI IN DETERMINING THE CARDIOMETABOLIC RISK PROFILE OF OBESE PEOPLE?

Arquivos Brasileiros De Cirurgia Digestiva : ABCD = Brazilian Archives of Digestive Surgery
Andressa Bressan MalafaiaBruno Luiz Ariede
January 12, 2022
Review
Open Access

Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future.

International Journal of Molecular Sciences
João Paulo Margiotti Dos SantosSandra Maria Barbalho
January 12, 2022
Open Access

Incidence and Risk Factors for Progression to Diabetes Mellitus: A Retrospective Cohort Study.

International Journal of Environmental Research and Public Health
Min Kyung HyunSeon Mi Ji
January 12, 2022
Review

Gut Microbiota and Complications of Type-2 Diabetes.

Nutrients
Camelia Oana IatcuMihai Covasa
January 12, 2022

The metabolic triad of NAFLD, visceral adiposity and type 2 diabetes: implications for treatment.

Diabetes, Obesity & Metabolism
Bertrand Cariou
January 11, 2022

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.

Circulation
Joshua J JosephAmerican Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arterioscle
January 11, 2022
Review
Open Access

The Glucagon-Like Adipokinetic Hormone in Drosophila melanogaster - Biosynthesis and Secretion.

Frontiers in Physiology
Bryon N Hughson

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

serum cholesterol, triglycerides, apolipoprotein b (apob)-containing lipoproteins (very low-density lipoprotein [vldl], immediate-density lipoprotein [idl], and low-density lipoprotein [ldl]), lipoprotein(a) (lp[a]), and the total cholesterol/high-density lipoprotein (hdl) cholesterol ratio are all connected in diseases. Discover the latest research on these molecules here.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

© 2022 Meta ULC. All rights reserved
/feed-previews/metabolic-syndrome-t2dm/274b0828-3344-4988-80b6-821b5b3b85eb